Global Therapeutic Proteins and Oral Vaccines Market

Report ID : 1037 | Published : 2022-08-17 | Pages: 140 | Format: PDF/EXCEL

According to the latest research by InsightAce Analytic, the global Therapeutic Proteins and Oral Vaccines market is valued at US$ 219.89 Billion in 2021, and it is expected to grow with a CAGR of 7.08% during a forecast period of 2022-2030. Therapeutic proteins are genetically engineered proteins that have a wide range of treatment applications. Therapeutic proteins are mainly prepared for pharmaceutical use. Oral vaccines are biologically prepared products, which are used in treating or preventing various infectious diseases. The increasing number of pharmaceutical drug developments or innovations is expected to drive the growth of the therapeutic protein and oral vaccine market in the near future.
Major driving factors of the therapeutic proteins and oral vaccines market are the increasing need for therapeutic proteins and oral vaccines, high prevalence of cancer diseases, rising number of clinical trials, increasing investments by key players for the development of promising therapies. Furthermore, advanced medical technologies, growth in the population, and a growing number of health-conscious people are enhancing the growth of the therapeutic proteins and oral vaccines market. However, the high price of devices, complex procedures, lack of strict government laws are restraining the growth of this market.


The therapeutic proteins and oral vaccines market is segmented into Drug Class, Distribution Channels, Applications, and regions. The Drug Class segment is further bifurcated into Therapeutic Proteins and Oral Vaccines. Therapeutic Proteins are subdivided into Therapeutic Proteins, Growth Factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Coagulation Factors, and Other Therapeutic Proteins. While, Oral Vaccines are subdivided into Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Other Oral Vaccines. In the coming future, therapeutic proteins will be in high scope due to their effective and fast results and rise in therapy innovations. By Distribution Channels, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies will upscale the market of therapeutic proteins and oral vaccines over the forecast period. In terms of Applications, the market can be divided into Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Other Applications. Oncology and Infectious diseases are the fastest-growing segments of this market due to the increasing prevalence of cancer and infectious diseases. Based on the region, the therapeutic proteins and oral vaccines market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America followed by Europe holds the maximum share of this market due to increased research and development expenditure, presence of significant market players and fast adaption of advanced technologies.
Major key Players of therapeutic proteins and oral vaccines market are Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd, Lumen Bioscience, Inc., and Other Prominent Players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Therapeutic Proteins and Oral Vaccines Market Snapshot

Chapter 4. Global Therapeutic Proteins and Oral Vaccines Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Drug Class, Estimates & Trend Analysis

5.1. By Drug Class, & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Drug Class:

5.2.1. Therapeutic Proteins

5.2.1.1.  Growth Factors

5.2.1.2.  Fusion Proteins

5.2.1.3.  Monoclonal Antibodies

5.2.1.4.  Hormones

5.2.1.5.  Coagulation Factors

5.2.1.6.  Other Therapeutic Proteins

5.2.2. Oral Vaccines

5.2.2.1.  Live Attenuated Vaccine

5.2.2.2.  Inactivated Vaccine

5.2.2.3.  Recombinant Vaccine

5.2.2.4.  Other Oral Vaccines

Chapter 6. Market Segmentation 1: By Distribution Channels Estimates & Trend Analysis

6.1. By Distribution Channels & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Distribution Channels:

6.2.1. Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online Pharmacies

Chapter 7. Market Segmentation 1: By Applications Estimates & Trend Analysis

7.1. By Applications & Market Share, 2020& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Applications:

7.2.1. Oncology

7.2.2. Hematology

7.2.3. Immunology

7.2.4. Endocrinology

7.2.5. Infectious Disease

7.2.6. Cardiovascular Disease

7.2.7. Other Applications

Chapter 8. Therapeutic Proteins and Oral Vaccines Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Drug Class, 2020-2030

8.1.2. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Distribution Channels, 2020-2030

8.1.3. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Applications, 2020-2030

8.1.4. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

8.2. Europe

8.2.1. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2020-2030

8.2.2. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2020-2030

8.2.3. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2020-2030

8.2.4. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2020-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2020-2030

8.3.2. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2020-2030

8.3.3. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2020-2030

8.3.4. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2020-2030

8.4. Latin America

8.4.1. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million)

8.4.2. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million)

8.4.3. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million)

8.4.4. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2020-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million)

8.5.2. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million)

8.5.3. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million)

8.5.4. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2020-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Abbott Laboratories

9.2.2. Amgen, Inc.

9.2.3. Biogen, Inc.

9.2.4. Eily, Lilly, and Company

9.2.5. F. Hoffmann-La Roche

9.2.6. Johnson and Johnson

9.2.7. Merck & Co.

9.2.8. Novo Nordisk

9.2.9. Pfizer, Inc.

9.2.10. Sanofi S.A.

9.2.11. Serum Institute of India Pvt. Ltd.

9.2.12. Emergent Biosolutions Inc.

9.2.13. TransAlgae

9.2.14. MigVax Ltd

9.2.15. Lumen Bioscience, Inc.

9.2.16. Neurelis, Inc.

9.2.17. Other Prominent Player

Global Therapeutic Proteins and Oral Vaccines Market Segmentation

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Drug Class

  • Therapeutic Proteins
  • Growth Factors
  • Fusion Proteins
  • Monoclonal Antibodies
  • Hormones
  • Coagulation Factors
  • Other Therapeutic Proteins
  • Oral Vaccines
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Recombinant Vaccine
  • Other Oral Vaccines

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Applications

  • Oncology
  • Hematology
  • Immunology
  • Endocrinology
  • Infectious Disease
  • Cardiovascular Disease
  • Other Applications

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 2019 To 2030

  • U.S.
  • Canada

Europe Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 2019 To 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 2019 To 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 2019 To 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 2019 To 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Our Clients

Media Citations

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals

Review Request

We’ll review your request & send a personalized quote for cost and time needed

Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..